Acelyrin, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 381.64 million compared to USD 64.77 million a year ago. Basic loss per share from continuing operations was USD 5.43 compared to USD 41.59 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 USD | -4.13% |
|
-6.28% | -43.97% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.97% | 414M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- SLRN Stock
- News Acelyrin, Inc.
- Acelyrin, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023